Ronna E. Dornsife

1.7k citations

25 papers · 1.4k indexed · h-index 16

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 6
- HIV Research and Treatment 6
Infectious Diseases 10
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 2

Co-authors: D R Averett (6 shared papers)Wayne H. Miller (2 shared papers)Steven S. Good (2 shared papers)George W. Koszalka (5 shared papers)M H St Clair (3 shared papers)Margaret Tisdale (4 shared papers)N. R. Parry (2 shared papers)John E. Reardon (2 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (8 papers)British Journal of Cancer (1 paper)Leukemia Research (1 paper)Nature (1 paper)Antiviral Research (1 paper)
Partner nations: United States China United Kingdom

In The Last Decade

Ronna E. Dornsife

23 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ronna E. Dornsife

Since Specialization

Citations

This map shows the geographic impact of Ronna E. Dornsife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronna E. Dornsife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronna E. Dornsife more than expected).

Fields of papers citing papers by Ronna E. Dornsife

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronna E. Dornsife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronna E. Dornsife. The network helps show where Ronna E. Dornsife may publish in the future.

Co-authors

The 25 scholars most cited alongside Ronna E. Dornsife, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronna E. Dornsife Line = papers co-authored together Ronna E. Dornsife links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity Antimicrobial Agents and Chemotherapy ·Susan M. Daluge, Steven S. Good, M B Faletto, Wayne H. Miller, M H St Clair, Lawrence R. Boone, Margaret Tisdale, N. R. Parry, John E. Reardon, Ronna E. Dornsife, D R Averett, Thomas A. Krenitsky	1997	323
2	Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of Action Antimicrobial Agents and Chemotherapy ·Karen K. Biron, Richard J. Harvey, Stanley C. Chamberlain, Steven S. Good, Albert A. Smith, Michelle G. Davis, Christine L. Talarico, Wayne H. Miller, Robert G. Ferris, Ronna E. Dornsife, Sylvia C. Stanat, John C. Drach, Leroy B. Townsend, George W. Koszalka	2002	295
3	The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine Antimicrobial Agents and Chemotherapy ·P A Furman, M. Davis, Dennis C. Liotta, Melanie Paff, Lloyd Frick, Donald J. Nelson, Ronna E. Dornsife, Julie A. Wurster, Lawrence J. Wilson, James A. Fyfe	1992	197
4	Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation Nature ·Peter W. Gasper, M. A. Thrall, David A. Wenger, Dennis W. Macy, Luc Van Ham, Ronna E. Dornsife, KIT MCBILES, Sandra L. Quackenbush, M. Lynne Kesel, Edward L. Gillette, Edward A. Hoover	1984	75
5	Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells Antimicrobial Agents and Chemotherapy ·Ronna E. Dornsife, M H St Clair, A T Huang, Timothy J. Panella, George W. Koszalka, C.L. Burns, D R Averett	1991	68
6	Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proceedings of the National Academy of Sciences ·N Riedel, E A Hoover, Ronna E. Dornsife, James I. Mullins	1988	64
7	Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides Antimicrobial Agents and Chemotherapy ·N. A. VAN DRAANEN, Margaret Tisdale, N. R. Parry, R Jansen, Ronna E. Dornsife, Joel V. Tuttle, D R Averett, George W. Koszalka	1994	49
8	Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol Antimicrobial Agents and Chemotherapy ·V. NAIR, M H St Clair, John E. Reardon, Harvey C. Krasny, Richard Hazen, Melanie Paff, Lawrence R. Boone, Margaret Tisdale, Isabel Nájera, Ronna E. Dornsife	1995	44
9	Identification and Optimization of 4‐Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase ChemMedChem ·Christopher R. M. Asquith, Tuomo Laitinen, James M. Bennett, Paulo H. Godoi, Michael P. East, Graham J. Tizzard, Lee M. Graves, Gary L. Johnson, Ronna E. Dornsife, Carrow I. Wells, Jonathan M. Elkins, Timothy M. Willson, William J. Zuercher	2017	38
10	Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models British Journal of Cancer ·I K Dev, Ronna E. Dornsife, Teresa M. Hopper, James A. Onori, Charles G. Miller, L.E. Harrington, Karen M. Dold, Robert J. Mullin, Jennifer H. Johnson, Renae M. Crosby, Aimee Truesdale, Andrea H. Epperly, K. W. HINKLE, Mui Cheung, Jeffrey A. Stafford, Deirdre K. Luttrell, Rakesh Kumar	2004	35
11	An Enantiospecific Synthesis of the Human Cytomegalovirus Antiviral Agent [(R)-3-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic Acid Journal of Medicinal Chemistry ·Stanley D. Chamberlain, Karen K. Biron, Ronna E. Dornsife, D R Averett, Lilia M. Beauchamp, George W. Koszalka	1994	21
12	The anti-human immunodeficiency virus agent 3'-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells Antimicrobial Agents and Chemotherapy ·Rebecca Sundseth, S S Joyner, John T. Moore, Ronna E. Dornsife, I K Dev	1996	21
13	In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans Antimicrobial Agents and Chemotherapy ·Ronna E. Dornsife, D R Averett	1996	20
14	Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats. PubMed ·R. W. Fulton, Peter W. Gasper, Gregory K. Ogilvie, TC Boone, Ronna E. Dornsife	1991	20
15	Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus Leukemia Research ·Ronna E. Dornsife, Peter W. Gasper, James I. Mullins, Edward A. Hoover	1989	19
16	JUUL e-liquid exposure elicits cytoplasmic Ca2+ responses and leads to cytotoxicity in cultured airway epithelial cells Toxicology Letters ·Rui Zhang, Myles M. Jones, Ronna E. Dornsife, Tongde Wu, Vijay Sivaraman, Robert Tarran, Rob U. Onyenwoke	2020	15
17	141W94 Drugs of the Future ·G.R. Painter, S. Ching, D. Reynolds, M.S. Clair, Brian M. Sadler, M. Elkins, R. Blum, Ronna E. Dornsife, D. Jim Livingston, J.A. Partadelis, S. Pazhanisamy, Roger D. Tung, Margaret Tisdale	1996	11
18	In vitro erythrocytopathic activity of an aplastic anemia-inducing feline retrovirus. PubMed ·Ronna E. Dornsife, Peter W. Gasper, James I. Mullins, E A Hoover	1989	10
19	Acute vaping exacerbates microbial pneumonia due to calcium (Ca2+) dysregulation PLoS ONE ·Rui Zhang, Myles M. Jones, De’Jana Parker, Ronna E. Dornsife, Nathan Wymer, Rob U. Onyenwoke, Vijay Sivaraman	2021	9
20	In Vitro Infection of Human Bone Marrow by Feline Leukemia Viruses Virology ·Richard A. Morgan, Ronna E. Dornsife, W.F. Anderson, Edward A. Hoover	1993	9

About Ronna E. Dornsife

Ronna E. Dornsife is a scholar working on Virology, Infectious Diseases, Epidemiology, Physiology and Genetics, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers), Virus-based gene therapy research (5 papers), Cytomegalovirus and herpesvirus research (5 papers), Smoking Behavior and Cessation (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), HIV/AIDS Research and Interventions (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Virology (426 citations), Infectious Diseases (613 citations), Epidemiology (559 citations), Hepatology (93 citations) and Organic Chemistry (249 citations). Ronna E. Dornsife has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include D R Averett, Wayne H. Miller, Steven S. Good, George W. Koszalka, M H St Clair, Margaret Tisdale, N. R. Parry, John E. Reardon, Lawrence R. Boone and Thomas A. Krenitsky. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, British Journal of Cancer, Leukemia Research, Nature and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact